Newsbot

ISC Announces Annual Guidance and Outlook for 2026

REGINA, Saskatchewan, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Information Services Corporation (TSX:ISC) (ISC, we or the Company) today announced its annual guidance and outlook for 2026.

Goldman Sachs resets Fed rate cut outlook under Warsh

Jerome Powell is out, Kevin Warsh is in. At least, thats the plan. Powells term ends on May 15, and President Trumps nomination of Warsh is expected to sail through Congress relatively easily. The nomination of Warsh took Wall Street by surprise, given the White Houses at-times fierce criticism ...

Billionaire Clan Said to Weigh $2 Billion Thai Summit Sale

Thai Summit Group, the Southeast Asian country’s largest auto-parts manufacturer, is weighing a sale of its business amid mounting pressure from the global shift to electric vehicles, political uncertainty and family succession gaps, according to people familiar with the matter.

CN’s 2025 Annual Financial Statements and Annual Information Form available on Company Website

MONTREAL, Feb. 04, 2026 (GLOBE NEWSWIRE) -- CN (TSX: CNR) (NYSE: CNI) announced today that the Company’s 2025 Annual Financial Statements, Notes thereto and Management’s Discussion and Analysis, and its 2025 Annual Information Form and Form 40-F, have been filed with Canadian and U.S. securities regulators and are now available in the “Investors” section of its website, www.cn.ca/investors.

XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems

CALGARY, Alberta, Feb. 04, 2026 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that further to its press release of October 17, 2025 and an update on December 31, 2025, the Company has entered into an extension agreement with Vectus Biosystems Limited (“Vectus”) to allow further time...

YC’s 2026 Roadmap Signals A Shift From Human-Augmented To AI-Native Startups

Y Combinator has released its Spring 2026 Request for Startups, with a clear message: artificial intelligence has moved beyond transforming software. Six of the seven highlighted opportunities center on AI systems that actively replace humans rather than assist them. This may be venture capitals clearest signal yet that the industry is betting on automation over augmentation.

Onego Bio stärkt Board of Directors durch Ernennung von Dr. Antti Vasara

HELSINKI--(BUSINESS WIRE)--Onego Bio, ein Lebensmittelzutatenhersteller, der mithilfe präziser Fermentation* tierfreies Eiprotein produziert, gab heute bekannt, dass Dr. Antti Vasara in sein Board of Directors berufen wurde. Dr. Vasara verfügt über mehr als 25 Jahre globale Erfahrung in Wissenschaft, Technologie und Geschäftsstrategie. Zuletzt war er als President und CEO von VTT Technical Research Centre of Finland tätig, wo er eine der führenden Deep-Tech-Forschungsorganisationen Europas leit

Texas Instruments makes a $7.5B deal no one saw coming

In a move that caught Wall Street off guard, semiconductor giant Texas Instruments (TI) revealed that it is acquiringSilicon Labs. The news comes a week after TI announced its fourth-quarter earnings on Jan. 27, and coincides with Silicon Labs’ Q4 report, released Feb. 4. Post-acquisition, TI stock ...

Ausblick: BBVA präsentiert Quartalsergebnisse

BBVA lässt sich am 05.02.2026 in die Bücher schauen: Auf der vierteljährlichen Finanzkonferenz wird BBVA die Bilanz zum am 31.12.2025 beendeten Jahresviertel offenlegen.Die ...

Free investing class by United Way starts Feb. 24

United Way of the Yampa Valley is hosting a complimentary, three-part, free investing class starting Feb. 24 in Steamboat Springs. The course will teach participants how to live a life of financial security by learning...

Ausblick: Sony zieht Bilanz zum jüngsten Jahresviertel

Sony wird am 05.02.2026 die Bilanz zum am 31.12.2025 abgelaufenen Quartal präsentieren.Die Schätzungen von 5 Analysten gehen beim Ergebnis je Aktie von durchschnittlich 61,48 JPY aus. Damit hätte sich ...